P3 Health Partners Inc. (PIII) Misses Q2 EPS by 11c, provides guidance

P3 Health Partners Inc. (NASDAQ: PIII) reported Q2 EPS of ($0.15), $0.11 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $379.2 million versus the consensus estimate of $383.49 million.

GUIDANCE:

P3 Health Partners Inc. sees FY2024 revenue of $1.45-1.55 billion, versus the consensus of $1.522 billion.

For earnings history and earnings-related data on P3 Health Partners Inc. (PIII) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• JPMorgan Double Upgrades Hemnet Group AB (HEM:SS) to Overweight
• Barclays Upgrades Schott Pharma AG (1SXP:GR) to Overweight